Freshworks (NASDAQ:FRSH – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a ...

Welcome to a new edition of ETtech Unwrapped – our weekend newsletter packed with the most important stories this week. Lets ...

Advance Auto (NYSE:AAP), and Freshworks (NASDAQ:FRSH) to its portfolio in Q4 2024, while exiting Smartsheet (SMAR), CBRE (NYSE:CBRE), and Monday.com (NASDAQ:MNDY), it disclosed in its 13F filing on ...

State of Alaska Department of Revenue lowered its stake in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 74.3% during the fourth quarter, according to the company in its most recent disclosure with ...

Freshworks (NASDAQ:FRSH – Get Free Report) had its price target raised by equities research analysts at Barclays from $14.00 to $20.00 in a research note issued on Wednesday,Benzinga reports. The firm ...

Freshworks Inc. (NASDAQ:FRSH – Get Free Report) gapped up before the market opened on Wednesday after StockNews.com upgraded the stock from a hold rating to a buy rating. The stock had previously ...

IPG Photonics Co. (NASDAQ:IPGP – Get Free Report) hit a new 52-week low during mid-day trading on Wednesday following a ...

Upstart Holdings, Inc. (NASDAQ:UPST – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Wednesday after the company announced better than expected quarterly earnings. The ...

Shares of Verona Pharma plc (NASDAQ:VRNA – Get Free Report) reached a new 52-week high on Wednesday after Canaccord Genuity Group raised their price target on the stock from $44.00 to $72.00.

CME Group Inc. (NASDAQ:CME – Get Free Report) reached a new 52-week high on Wednesday after the company announced better than expected quarterly earnings. The stock traded as high as $253.53 and last ...

Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Wednesday following a better than expected earnings announcement. The company ...

Freshworks' stock dip post-strong Q4 results offers a buying opportunity. See why I'm reiterating my buy rating with a $21 ...